Clinical Trial Update: Myoglobin Removal by High Cut-off CVVHD [NA]

View source ↗

Summary

This clinical trial update notes the completion of a study on myoglobin removal by high cut-off CVVHD in patients with rhabdomyolysis and renal failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Failure
• Rhabdomyolysis

Snippet

Sponsor: Vantive Health LLC | Conditions: Rhabdomyolysis, Renal Failure | NA | Status: COMPLETED